Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Levocetirizine with Capecitabine and Bevacizumab in Refractory Colorectal Cancer
NCT01722162Phase 2Completed
- Sponsor
- Washington University School of Medicine
- Start
- Apr 2013
- Primary completion
- Oct 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of levocetirizine in colorectal cancer (CRC), sponsored by Washington University School of Medicine. Started Apr 2013; status: completed.
02
Drugs
levocetirizine
03
Conditions
colorectal cancer (CRC)
Beyond the preview
Go deeper on NCT01722162.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01722162.